Zobrazeno 1 - 10
of 34
pro vyhledávání: '"J C, Kelder"'
Autor:
J. Peper, J. Schaap, J. C. Kelder, B. J. W. M. Rensing, D. E. Grobbee, T. Leiner, M. J. Swaans
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Multiple non-invasive tests are performed to diagnose coronary artery disease (CAD), but all are limited to either anatomical or functional assessments. Computed tomography derived Fractional Flow Reserve (CT-FFR) based on patient-specific l
Externí odkaz:
https://doaj.org/article/ec4fbbf6221f4e2ebef9b85b03cc0b5a
Publikováno v:
Skin Health and Disease, Vol 2, Iss 1, Pp n/a-n/a (2022)
Summary Background Based on studies at tertiary centres it is known that patch test reading on Day (D) 7 may show additional positive reactions. Female gender, higher age and allergen groups of topicals and corticosteroids were identified as predicti
Externí odkaz:
https://doaj.org/article/3dbb32fe617440e1864773c7f0d5c5b9
Autor:
K L, Zheng, W L, Bor, L M, Vernooij, N C, Breet, J C, Kelder, C M, Hackeng, R H J, Kropman, J M, Ten Berg, P G, Noordzij
Publikováno v:
Thrombosis Research, 218, 177-185. Elsevier Science
BACKGROUND: Postoperative myocardial injury (PMI) after major vascular surgery, detected by elevated cardiac troponin (cTn), has been associated with morbidity and mortality. It is unclear whether the pathophysiology of PMI is determined by increased
Publikováno v:
Netherlands Heart Journal. 30:160-171
Purpose Invasive fractional flow reserve (FFR), the reference standard for identifying significant coronary artery disease (CAD), can be estimated non-invasively by computed tomography-derived fractional flow reserve (CT-FFR). Commercially available
Publikováno v:
Skin Health and Disease. 2
Based on studies at tertiary centres it is known that patch test reading on Day (D) 7 may show additional positive reactions. Female gender, higher age and allergen groups of topicals and corticosteroids were identified as predictive factors.The firs
Autor:
J. C. Kelder, Repke J. Snijder, M.C. Post, L. ten Klooster, Johannes J. Mager, M.C.J. van Thor
Publikováno v:
Lung. 197:753-760
Research comparing bosentan and macitentan in chronic thromboembolic pulmonary hypertension (CTEPH) is scarce, although macitentan might have superior pharmacologic properties. We present the first real-world, 2-year follow-up results and compare cli
Publikováno v:
International Journal of Cardiology. Heart & Vasculature
International Journal of Cardiology: Heart & Vasculature, Vol 29, Iss, Pp 100544-(2020)
Int J Cardiol Heart Vasc
International Journal of Cardiology: Heart & Vasculature, Vol 29, Iss, Pp 100544-(2020)
Int J Cardiol Heart Vasc
Highlights • Long-term overall survival of CTEPH patients receiving PH-specific medial therapy is very reasonable. • Despite worse baseline characteristics at baseline, combination therapy showed similar survival as monotherapy. • Combination t
Autor:
J. C. Kelder, Evert-Jan ter Borg
Publikováno v:
International Journal of Rheumatic Diseases. 20:875-881
Aim To test the hypothesis that systemic auto-antibodies or hypergammaglobulinemia are related to the prevalence of extra-glandular tissue organ damage (EGOD) in primary Sjogren's syndrome (SS). Methods A real practice-based investigation of a relati
Autor:
J. C. Kelder, E. J. Ter Borg
Publikováno v:
Rheumatology International. 37:1153-1158
To investigate in a long-term study, the development of new extra-glandular manifestations (EGM) or associated auto-immune diseases (AID) from 1 year after establishing the diagnosis of primary Sjögren's syndrome (pSS). The primary goal was to exami
Autor:
W. Vreuls, J.O. Barentsz, M. G. van der Leest, D.M. Somford, J. A. Kummer, P. C. de Bruin, O. Wegelin, J. E. Nuininga, J. L.H.R. Bosch, T. F. de Vocht, Leonie Exterkate, J. C. Kelder, H. H.E. van Melick
Publikováno v:
Tijdschrift voor Urologie, 9(8), 146. Springer Science + Business Media
De FUTURE-trial is een multicenter gerandomiseerde studie naar drie technieken van MRI-geleide target biopten (TB’s) bij patienten na negatieve systematische biopten (SB’s) en blijvende verdenking op prostaatkanker. Tussen 2014 en 2017 onderginge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97cac11d52c26707dd75e0e64852c14f
https://dspace.library.uu.nl/handle/1874/392517
https://dspace.library.uu.nl/handle/1874/392517